Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 11/20 | 0.55 |
| ▸ | MMP9 | P14780 | 10/20 | 0.55 |
| ▸ | MMP12 | P39900 | 10/20 | 0.55 |
| ▸ | MMP1 | P03956 | 7/20 | 0.55 |
| ▸ | MMP3 | P08254 | 7/20 | 0.55 |
| ▸ | MMP13 | P45452 | 7/20 | 0.55 |
| ▸ | MMP14 | P50281 | 7/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 4/20 | 0.44 |
| ▸ | MMP16 | P51512 | 4/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 5/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5264611 | 0.83 | MMP2 (0.52) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL4075567 | 0.80 | HTR2A (0.50) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL3157307 | 0.80 | CYP2D6 (0.80) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL3157305 | 0.80 | CYP2D6 (0.80) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL4073428 | 0.78 | PTGS2 (0.48) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL4074718 | 0.78 | PTGS1 (0.38) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL4486237 | 0.77 | HSD11B1 (0.51) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL4072144 | 0.77 | MMP2 (0.47) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL4070632 | 0.76 | MMP1 (0.43) | MMP2MMP9MMP12MMP1MMP3 | |
| SCHEMBL4068694 | 0.76 | MMP1 (0.45) | MMP2MMP9MMP12MMP1MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7592456-B2 | Arylsulfonylnaphthalene derivatives as 5HT2A antagonists | MERCK SHARP & DOHME LIMITED (GB) | 2009-09-22 | — | — | US | claimed |
| US-20070281952-A1 | Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists | MERCK SHARPE & DOHME LIMITED (GB) | 2007-12-06 | — | — | US | claimed |
| US-7592456-B2 | Arylsulfonylnaphthalene derivatives as 5HT2A antagonists | MERCK SHARP & DOHME LIMITED (GB) | 2009-09-22 | — | — | US | disclosed |
| EP-1824817-B1 | ARYLSULFONYLNAPHTHALENE DERIVATIVES AS 5HT2A ANTAGONISTS | MERCK SHARP & DOHME (GB) | 2009-02-04 | — | — | EP | disclosed |
| US-20070281952-A1 | Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists | MERCK SHARPE & DOHME LIMITED (GB) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281952-A1 | Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists | HTR2A, HTR2C, HTR1A | MMP2 2787/4885MMP9 3988/4885MMP12 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.